At the Transplant Research and Education Center (TREC), we believe that rapid communication of information about COVID-19 vaccination to transplant patients and ongoing monitoring of patient outcomes are two important ways to keep our patients safe as we move forward into 2021. In the recent weeks, one of the many SARS-COV-2 vaccines being developed in the United States has been approved by the US Food and Drug Administration (FDA) for Emergency Use Authorization. This vaccine …
